AcelRx Pharmaceuticals, Inc. (ACRX) Social Stream



AcelRx Pharmaceuticals, Inc. (ACRX): $1.10

0.07 (+6.80%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add ACRX to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#137 of 168

in industry

ACELRX PHARMACEUTICALS INC (ACRX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ACRX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-17 3 $9 $4 $6 $1.03 482.52%
2021-11-16 3 $9 $4 $5.833 $1.03 466.31%
2021-12-02 2 $4.5 $4 $4.166 $1.03 304.47%
2022-03-11 3 $4.5 $4 $4.166 $1.03 304.47%
2022-08-12 2 $4 $4 $4 $1.03 288.35%
2022-11-15 1 $80 $80 $80 $1.03 7666.99%
2023-04-03 2 $80 $80 $80 $1.03 7666.99%

The Trend in the Analyst Price Target


Over the past 26 months, ACRX's average price target has gone up $74.54.

ACRX reports an average of 10,015.01% for its upside potential over the past 33 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-12 2 4 4 4 0.27 1381.48%
2022-08-12 2 80 80 80 0.27 29529.63%
2022-11-15 1 80 80 80 2.52 3074.6%
2022-11-15 2 80 80 80 2.52 3074.6%
2023-04-03 2 80 80 80 0.61 13014.75%

ACRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


ACRX's average broker recommendation rating improved by 0 over the prior 35 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACRX as an investment opportunity.

  • ACRX has a greater number of analysts covering the stock than 34.77% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ACELRX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 654.62% of them.
  • In the context of stocks in the small market cap category, ACELRX PHARMACEUTICALS INC's average analyst price target is greater than 239.32% of them.
  • ACRX has a lower variance in analysts' estimates than -49.72% of Healthcare stocks.

Stocks similar to ACELRX PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IBIO, AMPE, and VTGN.

Is ACRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7629 seconds.